Recomendaciones para reumatólogos sobre el manejo farmacológico durante la emergencia sanitaria por COVID-19: opinión de un grupo de expertos

Translated title of the contribution: Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion

Josué Guillermo López, Jhyld Carolaind Camacho-Barbosa, Oscar Jair Felipe-Díaz, Wilmer Gerardo Rojas-Zuleta, Jesús Giovanny Ballesteros, Erika Paola Navarro-Mendoza, Claudia Lucía Giraldo Herrera, Rodrigo Giraldo-Bustos, Lácides Padilla-Tovar, Natalia Duque-Zapata, Catalina Orozco González, María José López-Mora, Jorge Hernando Donado

Research output: Contribution to journalArticlepeer-review

Abstract

Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.

Translated title of the contributionRecommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion
Original languageSpanish
Pages (from-to)134-140
Number of pages7
JournalRevista Colombiana de Reumatologia
Volume28
Issue number2
DOIs
StatePublished - 1 Apr 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 Asociación Colombiana de Reumatología

Fingerprint

Dive into the research topics of 'Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion'. Together they form a unique fingerprint.

Cite this